Synopsis of recent research by authors named "Qiusui Mai"
- Qiusui Mai's research primarily focuses on developing innovative cellular therapies for treating hematological disorders, particularly targeting Epstein-Barr virus-associated lymphoproliferative disorders through engineered CAR-T cell approaches utilizing NKG2D receptor signaling.
- Mai has also contributed to the advancement of experimental models for bone metastasis, creating a precision experimental setup using magnetic micro-living-motor systems, enhancing the understanding of tumor behavior and the development of new treatments.
- Another area of Mai's research includes the enhancement of NK cell therapy by inducing memory-like NK cells for prolonged anti-tumor responses against B cell malignancies, alongside optimizing homing techniques for hematopoietic stem cells to improve transplantation outcomes.
